Latest

Health

·March 13, 2020·3 min read

Coronavirus spreads quickly and sometimes before people have symptoms

The time between cases in a chain of transmission of COVID-19 is less than one week, and more than 10% of patients are infected by someone who has the virus but is not yet symptomatic.

Featured Neuroscience Open Neuroscience Articles

·March 13, 2020·5 min read

Potential treatment for Lyme disease kills bacteria that may cause lingering symptoms

Mouse study reveals the antibiotic azlocillin completely kills off the Borrelia burgdorferi bacteria at the onset of Lyme disease. Findings also suggest the drug could be effective for treating patients infected with drug-tolerant bacteria that may cause lingering symptoms.

Featured Genetics Neuroscience

·March 13, 2020·7 min read

New COVID-19 diagnostic test could deliver results in less than 30 minutes

MIT researchers are working on a range of projects to help diagnose and slow the transmission of COVID-19. Researchers report they are developing a paper-based COVI-19 test that can deliver results within less than 30 minutes. They are currently submitting to the FDA for emergency use authorization, which would grant temporary approval for using the test on patient samples during public health emergencies. Another research team report they have developed an experimental RNA vaccine that is ready to test.

Featured Neuroscience

·March 13, 2020·1 min read

Research team has isolated the COVID-19 virus

A team of Canadian researchers has isolated SARS-CoV-2, the viral agent responsible for COVID-19. Isolating the virus will help researchers worldwide to develop better diagnostic tests, treatments, and vaccines for the pandemic virus. It will also help researchers to better understand the virus biology, evolution, and viral shedding.

Featured Genetics Neuroscience Open Neuroscience Articles

·March 12, 2020·4 min read

Researchers identify potential targets for immune response to COVID-19

Study provides first potential targets for effective immune responses against COVID-19. The findings provide essential information for vaccine design against SARS-CoV-2.

Featured Neuroscience Open Neuroscience Articles

·March 12, 2020·6 min read

Study details first known person-to-person transmission of new coronavirus in the USA

A new Lancet study describes the first locally-transmitted case of SARS-CoV-2, which causes COVID-19, in the USA from a woman who recently traveled to China and transmitted the infection to her husband.

Featured Neurology Neuroscience Open Neuroscience Articles

·March 11, 2020·4 min read

Common muscle relaxant given via nose shows potential to treat Alzheimer’s

Dantrolene, a common muscle relaxant, shows promise in the treatment of Alzheimer's disease. Mice administered the drug intranasally had higher concentrations of the medicine in their brains, and for longer periods, than those who received it orally. The drug has been shown to help inhibit or slow the progression of several neurodegenerative diseases.

This shows a woman and child in surgical masks

Featured Neuroscience Psychology

·March 10, 2020·4 min read

Knowing more about a virus threat may not satisfy you

People who rate themselves as highly knowledgeable about new viral infection threats could also be more likely to believe they don't know enough.

Featured Neuroscience Open Neuroscience Articles

·March 9, 2020·5 min read

5.1 days incubation period for COVID-19

Researchers report the median time from exposure to symptoms for the COVID-19 virus is 5.1 days. 97.5% of people who develop symptoms of coronavirus will do so within 11.5 days of exposure. For every 10,000 people quarantined for 14 days, an estimated 101 would develop symptoms after release.

Auditory Neuroscience Featured Neuroscience Open Neuroscience Articles Psychology

·March 6, 2020·4 min read

Music intervention and mindfulness reduces the effect of mental fatigue

On-the-spot binaural beats and daily mindfulness training can help reduce the effects of mental fatigue.

Featured Neuroscience Neuroscience Videos Open Neuroscience Articles

·March 6, 2020·3 min read

Potential drug to block coronavirus identified

A clinically proven drug known to block an enzyme essential for the viral entry of Coronavirus into the lungs blocks the COVID 19 (SARS-CoV-2) infection. The drug, Camostat mesilate, is a drug approved in Japan to treat pancreatic inflammation. Results suggest this drug may also protect against COVID 19. Researchers call for further clinical trials.

This shows a woman looking out of a window

Featured Neurology Neuroscience Psychology

·March 5, 2020·3 min read

Social isolation could cause physical inflammation

Socially isolated individuals may have an increased risk of physical inflammation in the body. Researchers found social isolation was associated with the presence of C-reactive protein and increased levels of glycoprotein fibrinogen. The link between social isolation and physical inflammation was more common in males.